In mid-March Germany's medicines regulator, the Paul Ehrlich Institute (PEI), was the first national health authority to flag what they described as an aberrantly high number of cases involving these rare cerebral blood clots, mostly in younger and middle-aged women.
from Top World News- News18.com https://ift.tt/3dzl38n
from Top World News- News18.com https://ift.tt/3dzl38n
Comments
Post a Comment